XOMA Corporation (XOMA) Financials
XOMA Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 234.3 million | 145.6 million |
2023-09-30 | 124.1 million | 18.1 million |
2023-06-30 | 125.7 million | 15.5 million |
2023-03-31 | 133.7 million | 19.1 million |
XOMA Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -18.6 million | 2.6 million |
2023-09-30 | -2.1 million | 2.7 million |
2023-06-30 | -7.2 million | 2.2 million |
2023-03-31 | -4.9 million | 1.6 million |
XOMA Net Income
No data available :(
XOMA Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 153.6 million | - | 389000 |
2023-09-30 | 33.7 million | - | - |
2023-06-30 | 31.8 million | - | 17000 |
2023-03-31 | 44.6 million | - | 69000 |
XOMA Shares Outstanding
XOMA Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 14.7 million | 25000 | 7.3 million | 1000 |
2023-09-30 | - | 25000 | 6.4 million | - |
2023-06-30 | - | 39000 | 5.8 million | - |
2023-03-31 | - | 54000 | 6.2 million | - |
XOMA Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 1.8 million | 225000 |
2023-09-30 | 830000 | 224000 |
2023-06-30 | 1.7 million | 224000 |
2023-03-31 | 437000 | 225000 |
XOMA
Price: $25.02
52 week price:
Earnings Per Share: -4.04 USD
P/E Ratio: -7.26
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 14100
Ebitda: 28.3 millionMarket Capitalization: 294.6 million